PDF herunterladen
Semin Thromb Hemost 2011; 37(2): 131-136
DOI: 10.1055/s-0030-1270339
© Thieme Medical Publishers

Platelet Function in Pre-Eclampsia

Rashid S. Kazmi1 , Alan J. Cooper2 , Bashir A. Lwaleed3
  • 1Department of Haematology, Southampton University Hospitals NHS Trust, Southampton
  • 2Department of Biomedical Sciences, Portsmouth University, Portsmouth, at the United Kingdom
  • 3Department of Urology, Southampton University Hospitals NHS Trust and School of Health Sciences, University of Southampton, Southampton General Hospital, Southampton, United Kingdom
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
02. März 2011 (online)

    Lizenzen und Reprints

ABSTRACT

Pronounced hemostatic changes occur during pregnancy, and the balance shifts markedly in favor of hypercoagulability. Although primarily a result of a marked rise in the levels of several procoagulants and a fall in some natural anticoagulants, platelet activation also contributes to this prothrombotic tendency. Several studies have confirmed the accentuation of platelet activation in pre-eclampsia (P-EC), which remains an important obstetric complication affecting ~2 to 4% of pregnancies. Although there is still a long way to go, significant inroads have been made in the understanding of this enigmatic condition. Whereas the pathogenesis of P-EC is protean and involves a complex interplay of placental and maternal tissues, platelet activation is likely to contribute to several clinical features. Several techniques have been used to assess platelet activation in P-EC. Detection of aberrations of platelet function and activation appear to have predictive value for its diagnosis. The findings also lend support to the use of antiplatelet agents as prophylaxis in those women with a high risk of developing the condition.

KEYWORDS

Pre-eclampsia - platelet activation

REFERENCES

  • 1 Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy . Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.  Am J Obstet Gynecol. 2000;  183 (1) S1-S22
    CrossrefPubMedSuche in Google Scholar
  • 2 American College of Obstetricians and Gynecologists .Hypertension in Pregnancy. ACOG Technical Bulletin No. 219. Washington, DC: The College; 1996: 1-8
    Suche in Google Scholar
  • 3 Khan K S, Wojdyla D, Say L, Gülmezoglu A M, Van Look P F. WHO analysis of causes of maternal death: a systematic review.  Lancet. 2006;  367 (9516) 1066-1074
    CrossrefPubMedSuche in Google Scholar
  • 4 Sibai B, Dekker G, Kupferminc M. Pre-eclampsia.  Lancet. 2005;  365 (9461) 785-799
    CrossrefPubMedSuche in Google Scholar
  • 5 Roberts J M, Taylor R N, Musci T J, Rodgers G M, Hubel C A, McLaughlin M K. Preeclampsia: an endothelial cell disorder.  Am J Obstet Gynecol. 1989;  161 (5) 1200-1204
    CrossrefPubMedSuche in Google Scholar
  • 6 Redman C W, Sacks G P, Sargent I L. Preeclampsia: an excessive maternal inflammatory response to pregnancy.  Am J Obstet Gynecol. 1999;  180 (2 Pt 1) 499-506
    CrossrefPubMedSuche in Google Scholar
  • 7 Roberts J M, Taylor R N, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia.  Am J Hypertens. 1991;  4 (8) 700-708
    PubMedSuche in Google Scholar
  • 8 Szecsi P B, Jørgensen M, Klajnbard A, Andersen M R, Colov N P, Stender S. Haemostatic reference intervals in pregnancy.  Thromb Haemost. 2010;  103 (4) 718-727
    Thieme ConnectPubMedSuche in Google Scholar
  • 9 Holthe M R, Staff A C, Berge L N, Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women.  Am J Obstet Gynecol. 2004;  190 (4) 1128-1134
    CrossrefPubMedSuche in Google Scholar
  • 10 Sill P R, Lind T, Walker W. Platelet values during normal pregnancy.  Br J Obstet Gynaecol. 1985;  92 (5) 480-483
    PubMedSuche in Google Scholar
  • 11 Sejeny S A, Eastham R D, Baker S R. Platelet counts during normal pregnancy.  J Clin Pathol. 1975;  28 (10) 812-813
    CrossrefPubMedSuche in Google Scholar
  • 12 Ahmed Y, van Iddekinge B, Paul C, Sullivan H F, Elder M G. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia.  Br J Obstet Gynaecol. 1993;  100 (3) 216-220
    PubMedSuche in Google Scholar
  • 13 Rinder H M, Bonan J L, Anandan S, Rinder C S, Rodrigues P A, Smith B R. Noninvasive measurement of platelet kinetics in normal and hypertensive pregnancies.  Am J Obstet Gynecol. 1994;  170 (1 Pt 1) 117-122
    PubMedSuche in Google Scholar
  • 14 Milman N, Bergholt T, Byg K E, Eriksen L, Hvas A M. Reference intervals for haematological variables during normal pregnancy and postpartum in 434 healthy Danish women.  Eur J Haematol. 2007;  79 (1) 39-46
    CrossrefPubMedSuche in Google Scholar
  • 15 Fay R A, Hughes A O, Farron N T. Platelets in pregnancy: hyperdestruction in pregnancy.  Obstet Gynecol. 1983;  61 (2) 238-240
    PubMedSuche in Google Scholar
  • 16 Rabini R A, Salvolini E, Staffolani R et al. Biochemical-morphological modifications of platelet membranes during pregnancy-induced hypertension.  Exp Mol Pathol. 1995;  63 (3) 175-185
    CrossrefPubMedSuche in Google Scholar
  • 17 Damron D P, Bouchard B A, Shapiro R E, Schonberg A L, Bernstein I M. Platelet activation, sympathetic tone, and plasma volume in nulligravid women of reproductive age.  Obstet Gynecol. 2004;  103 (5 Pt 1) 931-936
    CrossrefPubMedSuche in Google Scholar
  • 18 Morrison R, Crawford J, MacPherson M, Heptinstall S. Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension.  Thromb Haemost. 1985;  54 (3) 607-611
    PubMedSuche in Google Scholar
  • 19 Sheu J R, Hsiao G, Shen M Y, Lin W Y, Tzeng C R. The hyperaggregability of platelets from normal pregnancy is mediated through thromboxane A2 and cyclic AMP pathways.  Clin Lab Haematol. 2002;  24 (2) 121-129
    CrossrefPubMedSuche in Google Scholar
  • 20 Hayashi M, Kiumi F, Mitsuya K. Changes in platelet ATP secretion and aggregation during pregnancy and in preeclampsia.  Am J Med Sci. 1999;  318 (2) 115-121
    CrossrefPubMedSuche in Google Scholar
  • 21 Gerbasi F R, Bottoms S, Farag A, Mammen E. Increased intravascular coagulation associated with pregnancy.  Obstet Gynecol. 1990;  75 (3 Pt 1) 385-389
    PubMedSuche in Google Scholar
  • 22 Jungi T W, Spycher M O, Nydegger U E, Barandun S. Platelet-leukocyte interaction: selective binding of thrombin-stimulated platelets to human monocytes, polymorphonuclear leukocytes, and related cell lines.  Blood. 1986;  67 (3) 629-636
    PubMedSuche in Google Scholar
  • 23 Sarma J, Laan C A, Alam S, Jha A, Fox K A, Dransfield I. Increased platelet binding to circulating monocytes in acute coronary syndromes.  Circulation. 2002;  105 (18) 2166-2171
    CrossrefPubMedSuche in Google Scholar
  • 24 Kageyama K, Nakajima Y, Shibasaki M, Hashimoto S, Mizobe T. Increased platelet, leukocyte, and endothelial cell activity are associated with increased coagulability in patients after total knee arthroplasty.  J Thromb Haemost. 2007;  5 (4) 738-745
    CrossrefPubMedSuche in Google Scholar
  • 25 Robb A O, Din J N, Mills N L et al. The influence of the menstrual cycle, normal pregnancy and pre-eclampsia on platelet activation.  Thromb Haemost. 2010;  103 (2) 372-378
    Thieme ConnectPubMedSuche in Google Scholar
  • 26 Henn V, Slupsky J R, Gräfe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.  Nature. 1998;  391 (6667) 591-594
    Suche in Google Scholar
  • 27 Henn V, Steinbach S, Büchner K, Presek P, Kroczek R A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.  Blood. 2001;  98 (4) 1047-1054
    CrossrefPubMedSuche in Google Scholar
  • 28 Oron G, Ben-Haroush A, Hod M, Orvieto R, Bar J. Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia.  Obstet Gynecol. 2006;  107 (4) 896-900
    CrossrefPubMedSuche in Google Scholar
  • 29 Darmochwal-Kolarz D, Kolarz B, Surdacka A, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. The expression and concentration of CD40 ligand in normal pregnancy and pre-eclampsia.  J Reprod Immunol. 2009;  79 (2) 215-219
    CrossrefPubMedSuche in Google Scholar
  • 30 Heilmann L, Rath W, Pollow K. Hemostatic abnormalities in patients with severe preeclampsia.  Clin Appl Thromb Hemost. 2007;  13 (3) 285-291
    CrossrefPubMedSuche in Google Scholar
  • 31 Redman C W, Bonnar J, Beilin L. Early platelet consumption in pre-eclampsia.  BMJ. 1978;  1 (6111) 467-469
    CrossrefPubMedSuche in Google Scholar
  • 32 Dundar O, Yoruk P, Tutuncu L et al. Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia.  Prenat Diagn. 2008;  28 (11) 1052-1056
    CrossrefPubMedSuche in Google Scholar
  • 33 Howarth S, Marshall L R, Barr A L, Evans S, Pontre M, Ryan N. Platelet indices during normal pregnancy and pre-eclampsia.  Br J Biomed Sci. 1999;  56 (1) 20-22
    PubMedSuche in Google Scholar
  • 34 Coata G, Frusca T, Baranzelli D, Cosmi E V, Di Renzo G C, Anceschi M M. Abnormal platelet lipid membrane composition in pregnancy induced hypertension.  J Perinat Med. 1992;  20 (2) 123-127
    CrossrefPubMedSuche in Google Scholar
  • 35 Shang T, Qiao C. Study on the activity of platelets protein kinase C in patients with pregnancy induced hypertension.  [in Chinese] Zhonghua Fu Chan Ke Za Zhi. 1998;  33 (4) 201-203
    PubMedSuche in Google Scholar
  • 36 Takeuchi T, Yoneyama Y, Suzuki S, Sawa R, Otsubo Y, Araki T. Regulation of platelet aggregation in vitro by plasma adenosine in preeclampsia.  Gynecol Obstet Invest. 2001;  51 (1) 36-39
    CrossrefPubMedSuche in Google Scholar
  • 37 Socol M L, Weiner C P, Louis G, Rehnberg K, Rossi E C. Platelet activation in preeclampsia.  Am J Obstet Gynecol. 1985;  151 (4) 494-497
    PubMedSuche in Google Scholar
  • 38 Mellembakken J R, Solum N O, Ueland T, Videm V, Aukrust P. Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia—possible role of platelet activation.  Thromb Haemost. 2001;  86 (5) 1272-1276
    PubMedSuche in Google Scholar
  • 39 Peraçoli M T, Menegon F T, Borges V T, de Araújo Costa R A, Thomazini-Santos I A, Peraçoli J C. Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia.  J Reprod Immunol. 2008;  79 (1) 79-84
    CrossrefPubMedSuche in Google Scholar
  • 40 Louden K A, Broughton Pipkin F, Heptinstall S, Fox S C, Mitchell J R, Symonds E M. Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia.  Br J Obstet Gynaecol. 1991;  98 (12) 1239-1244
    CrossrefPubMedSuche in Google Scholar
  • 41 Norris L A, Gleeson N, Sheppard B L, Bonnar J. Whole blood platelet aggregation in moderate and severe pre-eclampsia.  Br J Obstet Gynaecol. 1993;  100 (7) 684-688
    CrossrefPubMedSuche in Google Scholar
  • 42 Nisell H, Grunewald C, Berglud M, Karlberg K E, Lunell N O, Sylven C. Platelet aggregation in vitro and ex vivo in normal pregnancy, pregnancy-induced hypertension and pre-eclampsia.  Hypertens Pregnancy. 1998;  17 (2) 147-155
    CrossrefPubMedSuche in Google Scholar
  • 43 Lev P R, Salim J P, Marta R F, Osorio M J, Goette N P, Molinas F C. Platelets possess functional TGF-beta receptors and Smad2 protein.  Platelets. 2007;  18 (1) 35-42
    CrossrefPubMedSuche in Google Scholar
  • 44 Janes S L, Kyle P M, Redman C, Goodall A H. Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia.  Thromb Haemost. 1995;  74 (4) 1059-1063
    PubMedSuche in Google Scholar
  • 45 Konijnenberg A, van der Post J A, Mol B W et al. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study.  Am J Obstet Gynecol. 1997;  177 (2) 434-442
    CrossrefPubMedSuche in Google Scholar
  • 46 Konijnenberg A, Stokkers E W, van der Post J A et al. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules.  Am J Obstet Gynecol. 1997;  176 (2) 461-469
    CrossrefPubMedSuche in Google Scholar
  • 47 Harlow F H, Brown M A, Brighton T A et al. Platelet activation in the hypertensive disorders of pregnancy.  Am J Obstet Gynecol. 2002;  187 (3) 688-695
    CrossrefPubMedSuche in Google Scholar
  • 48 Yoneyama Y, Suzuki S, Sawa R, Kiyokawa Y, Power G G, Araki T. Plasma adenosine levels and P-selectin expression on platelets in preeclampsia.  Obstet Gynecol. 2001;  97 (3) 366-370
    CrossrefPubMedSuche in Google Scholar
  • 49 Barnard M R, Linden M D, Frelinger III AL et al. Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity.  J Thromb Haemost. 2005;  3 (11) 2563-2570
    CrossrefPubMedSuche in Google Scholar
  • 50 Macey M, McCarthy D, Azam U, Milne T, Golledge P, Newland A. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood.  Cytometry B Clin Cytom. 2003;  51 (1) 30-40
    PubMedSuche in Google Scholar
  • 51 Del Conde I, Shrimpton C N, Thiagarajan P, López J A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.  Blood. 2005;  106 (5) 1604-1611
    CrossrefPubMedSuche in Google Scholar
  • 52 Holthe M R, Lyberg T, Staff A C, Berge L N. Leukocyte-platelet interaction in pregnancies complicated with preeclampsia.  Platelets. 2005;  16 (2) 91-97
    CrossrefPubMedSuche in Google Scholar
  • 53 Srinivas S K, Edlow A G, Neff P M, Sammel M D, Andrela C M, Elovitz M A. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension?.  J Perinatol. 2009;  29 (10) 680-684
    CrossrefPubMedSuche in Google Scholar
  • 54 Kühne T, Ryan G, Blanchette V et al. Platelet-surface glycoproteins in healthy and preeclamptic mothers and their newborn infants.  Pediatr Res. 1996;  40 (6) 876-880
    CrossrefPubMedSuche in Google Scholar
  • 55 Klein B, Faridi A, Amo-Takyi B K, Heilmann L, Von Tempelhoff G F, Rath W. Neonatal platelet activation in preeclampsia.  Clin Appl Thromb Hemost. 2001;  7 (1) 29-32
    CrossrefPubMedSuche in Google Scholar
  • 56 Clark D A. Tolerance signaling molecules.  Chem Immunol Allergy. 2005;  89 36-48
    PubMedSuche in Google Scholar
  • 57 Sato Y, Fujiwara H, Zeng B X, Higuchi T, Yoshioka S, Fujii S. Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries.  Blood. 2005;  106 (2) 428-435
    CrossrefPubMedSuche in Google Scholar
  • 58 Falconer J, Pineo G, Blahey W, Bowen T, Docksteader B, Jadusingh I. Essential thrombocythemia associated with recurrent abortions and fetal growth retardation.  Am J Hematol. 1987;  25 (3) 345-347
    CrossrefPubMedSuche in Google Scholar
  • 59 Vantroyen B, Vanstraelen D. Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature.  Acta Haematol. 2002;  107 (3) 158-169
    CrossrefPubMedSuche in Google Scholar

Rashid S KazmiM.R.C.P. F.R.C.Path. 

Department of Haematology, Southampton University Hospitals NHS Trust

Southampton, UK

eMail: syed.kazmi@suht.swest.nhs.uk